Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil.

View Abstract
Investigators
Abbreviation
BMJ Glob Health
Publication Date
2022-03-22
Volume
7
Issue
3
Pubmed ID
35277426
Medium
Print
Full Title
Ultraexpensive gene therapies, industry interests and the right to health: the case of onasemnogene abeparvovec in Brazil.
Authors
Ivama-Brummell AM, Wagner AK, Pepe VLE, Naci H